Join this live webinar to learn more.
The demand for complex therapeutic proteins, is rapidly accelerating, with the bispecific market alone projected to grow to $50B by 2030. While these atypical molecules offer transformative clinical potential, their complexity introduces significant manufacturing challenges, including extended development timelines, low expression levels, and stability issues across production steps. As pipelines grow more sophisticated, the need for standardized, scalable, and de-risked manufacturing strategies has never been greater.
Join us for an in-depth discussion on how to build processes to successfully develop and manufacture complex proteins. Drawing on real-world experience, this session will explore:
- The latest technologies for accelerating timelines
- Strategies for optimizing upstream production and analytical formulation of complex and unstable proteins
- Best practices for building robust, end-to-end processes that scale seamlessly from early development to cGMP manufacturing
- How to mitigate risk and enable faster progression to the clinic and beyond
- And more
Offered Free by: AGC Biologics
See All Resources from: AGC Biologics
